Full Text View
Tabular View
No Study Results Posted
Related Studies
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain
This study has been completed.
Study NCT01345045   Information provided by AbbVie

First Received on April 28, 2011.   Last Updated on January 3, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Neuropathic Pain
Additional conditions recognized in this trial
Neuralgia
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
ABT-639
pregabalin
Placebo
Additional drug interventions recognized in this trial
Analgesics
More general drug interventions related to this trial
Anticonvulsants
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
AbbVie (prior sponsor, Abbott)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services